Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine
Clinical trial NCT05748483 · COMPLETED
Trial details
- NCT number
- NCT05748483
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-07
- Primary completion
- 2025-04-28
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.